Cleveland Clinic Mellen Center for MS

Cleveland, Ohio 44195

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis

Studies at this site

• Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) — Stopped early
• A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS) — Completed